Wierzyciel SA
WSE:WRL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
W
|
Wierzyciel SA
WSE:WRL
|
PL |
|
M
|
Melewar Industrial Group Bhd
KLSE:MELEWAR
|
MY |
|
Guizhou BC&TV Information Network Co Ltd
SSE:600996
|
CN |
|
M
|
Mtag Group Bhd
KLSE:MTAG
|
MY |
|
Tetsujin Inc
TSE:2404
|
JP |
|
Iveco Group NV
MIL:IVG
|
IT |
|
Japan Hospice Holdings Inc
TSE:7061
|
JP |
|
InnoCare Pharma Ltd
SSE:688428
|
CN |
|
ARSS Infrastructure Projects Ltd
NSE:ARSSINFRA
|
IN |
Balance Sheet
Balance Sheet Decomposition
Wierzyciel SA
Wierzyciel SA
Balance Sheet
Wierzyciel SA
| Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
4
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
4
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
3
|
3
|
0
|
1
|
2
|
|
| Total Receivables |
3
|
7
|
9
|
11
|
13
|
14
|
14
|
15
|
16
|
13
|
10
|
8
|
7
|
6
|
6
|
5
|
5
|
5
|
4
|
|
| Accounts Receivables |
3
|
6
|
9
|
11
|
12
|
0
|
12
|
13
|
14
|
11
|
9
|
7
|
6
|
6
|
6
|
5
|
5
|
5
|
4
|
|
| Other Receivables |
0
|
0
|
1
|
1
|
1
|
0
|
2
|
2
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
4
|
7
|
10
|
12
|
13
|
14
|
15
|
15
|
16
|
13
|
11
|
11
|
10
|
10
|
9
|
8
|
7
|
8
|
8
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Assets |
4
N/A
|
8
+90%
|
10
+31%
|
12
+22%
|
14
+12%
|
15
+9%
|
15
0%
|
15
+4%
|
16
+2%
|
13
-18%
|
11
-12%
|
11
-4%
|
11
-3%
|
10
-5%
|
9
-8%
|
9
-8%
|
8
-5%
|
8
-3%
|
8
-1%
|
|
| Liabilities | ||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
1
|
2
|
1
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
1
|
1
|
1
|
0
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
2
|
1
|
0
|
1
|
2
|
3
|
5
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Debt |
0
|
2
|
2
|
1
|
3
|
0
|
2
|
2
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
3
+191%
|
4
+47%
|
3
-39%
|
3
+34%
|
4
+34%
|
4
-6%
|
5
+13%
|
5
+6%
|
2
-60%
|
0
-83%
|
0
-24%
|
0
-19%
|
0
+5%
|
0
N/A
|
0
+9%
|
0
+0%
|
0
+25%
|
0
-52%
|
|
| Equity | ||||||||||||||||||||
| Common Stock |
2
|
4
|
5
|
7
|
7
|
7
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
|
| Retained Earnings |
1
|
1
|
1
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
2
|
1
|
1
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
3
N/A
|
5
+58%
|
6
+21%
|
10
+65%
|
10
+6%
|
10
+1%
|
11
+2%
|
11
+0%
|
11
+0%
|
11
+2%
|
11
+1%
|
11
-3%
|
10
-3%
|
10
-5%
|
9
-8%
|
8
-8%
|
8
-5%
|
8
-4%
|
8
+1%
|
|
| Total Liabilities & Equity |
4
N/A
|
8
+90%
|
10
+31%
|
12
+22%
|
14
+12%
|
15
+9%
|
15
0%
|
15
+4%
|
16
+2%
|
13
-18%
|
11
-12%
|
11
-4%
|
11
-3%
|
10
-5%
|
9
-8%
|
9
-8%
|
8
-5%
|
8
-3%
|
8
-1%
|
|
| Shares Outstanding | ||||||||||||||||||||
| Common Shares Outstanding |
7
|
7
|
7
|
7
|
7
|
7
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
|